Mark Hahn, the Chief Financial Officer of Verona Pharma PLC (NASDAQ:VRNA), conducted a significant transaction on August 13, 2024, in which the insider sold 400,000 shares of the company’s stock. The sale was documented in a recent SEC filing. Following this transaction, the insider now owns 14,939,688 shares of Verona Pharma PLC. Verona Pharma PLC […]